Related Experiment Videos
Comprehensive screening of the human KRAS2 gene for sequence variants
E S Abrams1, S E Murdaugh, L S Lerman
1Dept. of Biology, Massachusetts Institute of Technology, Cambridge 02139.
Genes, Chromosomes & Cancer
|February 1, 1993
Summary
This study introduces a comprehensive method using polymerase chain reaction (PCR) and denaturing gradient gel electrophoresis to detect mutations in the KRAS2 oncogene. The technique efficiently identifies genetic alterations in coding exons and splice sites, crucial for cancer research.
Area of Science:
- Molecular biology
- Genetics
- Oncology
Background:
- The KRAS2 oncogene plays a critical role in cell signaling pathways.
- Mutations in KRAS2 are frequently observed in various human cancers.
- Accurate detection of KRAS2 mutations is essential for diagnosis and targeted therapy.
Purpose of the Study:
- To develop a comprehensive and sensitive method for detecting mutations in the human KRAS2 oncogene.
- To screen coding exons and splice sites of the KRAS2 gene for alterations.
- To identify novel polymorphic loci within the KRAS2 gene.
Main Methods:
- Utilized polymerase chain reaction (PCR) to amplify fragments of the human KRAS2 gene.
- Employed denaturing gradient gel electrophoresis (DGGE) for mutation analysis.
- Incorporated GC clamps via heteroduplex extension for enhanced fragment stability and detection.
- Analyzed six distinct PCR fragments covering five coding exons and splice sites.
- Used computer programs MELT and SQHTX for theoretical analysis of mutation detectability.
Main Results:
- The developed system demonstrated high sensitivity, theoretically capable of detecting virtually any single base-pair mutation.
- Successfully detected known missense mutations at codons 12, 13, and 61, common in KRAS2-mutated human tumors.
- Identified three previously unknown polymorphic loci within the KRAS2 gene.
- Showcased the efficiency of screening multiple PCR fragments (2-3) per gel lane, increasing throughput.
Conclusions:
- The described PCR-DGGE system provides a robust and comprehensive approach for mutation screening of the KRAS2 gene.
- This method facilitates the detection of critical mutations associated with cancer development.
- The discovery of new polymorphic loci may aid in future genetic association studies related to KRAS2.